Pharmacology Division, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study (UGC-CAS), Panjab University, Chandigarh, India.
Pharmacology Division, University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study (UGC-CAS), Panjab University, Chandigarh, India.
Pharmacol Rep. 2018 Apr;70(2):206-216. doi: 10.1016/j.pharep.2017.09.009. Epub 2017 Oct 2.
Neuropathic Pain (NP) is a painful condition which is a direct consequence of a lesion or disease affecting the somatosensory system with symptoms like allodynia, hyperalgesia. It has complex pathogenesis as it involves several molecular signaling pathways, thus numerous reliable animal models are crucial to understand the underlying mechanism of NP and formulate effective management therapy. Some models like spinal cord injury, chronic constriction injury, spinal nerve ligation, chemotherapy induced peripheral neuropathy, diabetes-induced NP and many more are discussed. This review contains an overview of the procedures followed to induce neuropathy and specific characteristics of that particular model. Some new techniques like spared nerve ligation, have omitted the limitation of methods not presently used where complete nerve damage occurs. Since animal models provide a window to experienced symptoms and physiology and impact the translation of bench discoveries to the bedside, the reporting, interpretation and comparison of these models is necessary because slight variation in procedure of model generation can drastically alter the results. The development of novel, but rational analgesic drugs to alleviate this intractable pain demands elucidation of molecular mechanisms of NP for which different types of animal models have been established.
神经病理性疼痛(NP)是一种疼痛病症,是直接影响躯体感觉系统的损伤或疾病的后果,其症状包括感觉异常、痛觉过敏等。由于涉及多个分子信号通路,其发病机制复杂,因此,许多可靠的动物模型对于理解 NP 的潜在机制和制定有效的管理治疗方法至关重要。本文讨论了一些模型,如脊髓损伤、慢性缩窄性损伤、脊神经结扎、化疗诱导的周围神经病变、糖尿病诱导的 NP 等。本文综述了诱导神经病的程序以及该特定模型的具体特征。一些新技术,如保留神经结扎术,避免了目前不完全神经损伤时使用的方法的局限性。由于动物模型为体验症状和生理学提供了一个窗口,并影响了从实验室发现到临床的转化,因此有必要对这些模型进行报告、解释和比较,因为模型生成过程中的微小差异可能会极大地改变结果。为了缓解这种难治性疼痛,需要开发新型但合理的镇痛药物,为此已经建立了不同类型的动物模型。
Pharmacol Rep. 2017-10-2
Cent Nerv Syst Agents Med Chem. 2012-12
Molecules. 2020-3-5
Eur Neuropsychopharmacol. 2015-11
J Neuroimmune Pharmacol. 2012-12-16
Eur J Pharmacol. 2018-2-4
Ugeskr Laeger. 1999-3-22
J Opioid Manag. 2011
Front Neurol. 2025-5-7
Bosn J Basic Med Sci. 2022-4-1